Stephen Gucker

Array ( [id] => 4329753 [patent_doc_number] => 06329566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Methods for the detection, treatment, and prevention of neurodegeneration' [patent_app_type] => 1 [patent_app_number] => 8/864785 [patent_app_country] => US [patent_app_date] => 1997-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 13985 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329566.pdf [firstpage_image] =>[orig_patent_app_number] => 864785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349625 [patent_doc_number] => 06291247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity' [patent_app_type] => 1 [patent_app_number] => 8/853910 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 24560 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291247.pdf [firstpage_image] =>[orig_patent_app_number] => 853910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915170 [patent_doc_number] => 06001970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Modified human neuropeptide Y1 Receptors' [patent_app_type] => 1 [patent_app_number] => 8/817869 [patent_app_country] => US [patent_app_date] => 1997-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14109 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001970.pdf [firstpage_image] =>[orig_patent_app_number] => 817869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021450 [patent_doc_number] => 05925542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Nucleic acid encoding human phosphodiesterase regulatory subunit' [patent_app_type] => 1 [patent_app_number] => 8/851188 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18173 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925542.pdf [firstpage_image] =>[orig_patent_app_number] => 851188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337565 [patent_doc_number] => 06333310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'NGF variants' [patent_app_type] => 1 [patent_app_number] => 8/845541 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22369 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333310.pdf [firstpage_image] =>[orig_patent_app_number] => 845541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353732 [patent_doc_number] => 06254869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Cryptopain vaccines, antibodies, proteins, peptides, DNA and RNA for prophylaxis, treatment and diagnosis and for detection of cryptosporidium species' [patent_app_type] => 1 [patent_app_number] => 8/827171 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 14991 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/254/06254869.pdf [firstpage_image] =>[orig_patent_app_number] => 827171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3806655 [patent_doc_number] => 05811245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Antibodies that specifically bind to ALK-7, a novel serine threonine kinase receptor' [patent_app_type] => 1 [patent_app_number] => 8/805169 [patent_app_country] => US [patent_app_date] => 1997-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14526 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811245.pdf [firstpage_image] =>[orig_patent_app_number] => 805169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3817458 [patent_doc_number] => 05789565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Serine threonine kinase receptor, ALK-7' [patent_app_type] => 1 [patent_app_number] => 8/805166 [patent_app_country] => US [patent_app_date] => 1997-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14529 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789565.pdf [firstpage_image] =>[orig_patent_app_number] => 805166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254202 [patent_doc_number] => 06207798 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Modified PE40 toxin fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/798447 [patent_app_country] => US [patent_app_date] => 1997-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207798.pdf [firstpage_image] =>[orig_patent_app_number] => 798447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1423433 [patent_doc_number] => 06503728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Pantropic neurotrophic factors' [patent_app_type] => B1 [patent_app_number] => 08/794028 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 74 [patent_no_of_words] => 22723 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503728.pdf [firstpage_image] =>[orig_patent_app_number] => 08794028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297191 [patent_doc_number] => 20040214756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'PHARMACEUTICALS FOR TREATING SEPSIS AND SEPTIC SHOCK' [patent_app_type] => new [patent_app_number] => 08/789406 [patent_app_country] => US [patent_app_date] => 1997-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1337 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214756.pdf [firstpage_image] =>[orig_patent_app_number] => 08789406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183869 [patent_doc_number] => 06153190 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Erythropoietin receptor antibodies' [patent_app_type] => 1 [patent_app_number] => 8/776511 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 16019 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153190.pdf [firstpage_image] =>[orig_patent_app_number] => 776511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079725 [patent_doc_number] => 06054283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Antibodies against human herpesvirus-6(HHV-6) and method of use' [patent_app_type] => 1 [patent_app_number] => 8/774118 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 8932 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054283.pdf [firstpage_image] =>[orig_patent_app_number] => 774118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876643 [patent_doc_number] => 20010006796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'VARIANT HUMAN ALPHA7 ACETYLCHOLINE RECEPTOR SUBNIT, AND METHODS OF PROD0U0CTION AND USES THEREOF' [patent_app_type] => new-utility [patent_app_number] => 08/771737 [patent_app_country] => US [patent_app_date] => 1996-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13695 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006796.pdf [firstpage_image] =>[orig_patent_app_number] => 08771737 [rel_patent_id] =>[rel_patent_doc_number] =>)